NCT06643884Phase 2Recruiting

Suprachoroidal Administration in Subjects With Metastases to the Choroid

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2026-11-30Estimated

Enrollment · participants24Estimated

Source updated2026-03-13Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-01-08 · 1 field changed

Primary completion date changed

− Before

~~31 Mar 2026~~

+ After

30 Nov 2026

Check registry source

Posted 2025-10-01 · 2 fields changed

Primary completion date changed

− Before

~~31 Jan 2026~~

+ After

31 Mar 2026

Recruitment status changed

− Before

~~Not yet recruiting~~

+ After

Recruiting

Check registry source

Study details

Conditions studied

Eye Cancer; Primary Cancer

Treatments or interventions studied

AU-011Drug

Primary outcomes · main study measures

Read the study measures

measure: Change from baseline in choroidal tumor thickness on B-scan ultrasonography (B-scan) 4 weeks after completion of treatment.; description: B-Scan Ultrasonography; timeFrame: 4 weeks after completion of treatment; measure: Change from baseline in choroidal tumor largest basal diameter (LBD) on fundus photos 4 weeks after completion of treatment.; description: Fundus photos; timeFrame: 4 weeks after completion of treatment

History coverage

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

How to read this history